How much funding has ANA Therapeutics raised?

ANA Therapeutics has raised $5.0M in total funding, most recently a Seed round.

Who are ANA Therapeutics's investors?

ANA Therapeutics's investors include SOSV, Sam Altman, Jack Abraham, Paul Buchheit, Refactor Capital, Blue Bear Capital.

When was ANA Therapeutics founded?

ANA Therapeutics was founded in 2020.

Where is ANA Therapeutics headquartered?

ANA Therapeutics is headquartered in Foster City, California, United States.

What industry is ANA Therapeutics in?

ANA Therapeutics operates in Biotech.

How many employees does ANA Therapeutics have?

ANA Therapeutics has 1-10 employees.

ANA Therapeutics

Acquired

Oral niclosamide antiviral treatment for COVID-19

Foster City, United States · Founded 2020 · $5.0M raised

Biotech

Headquarters: Foster City, California
Employees: 1–10
Founded: 2020
Business Model: B2B
Website: neurobopharma.com

Total Funding: $5.0M
Last Round: $5.0M SeedAug 2020
Rounds: 2
Acquisition Date: Jan 2021

About

ANA Therapeutics was a Silicon Valley-based clinical-stage biotechnology startup founded in 2020 to develop ANA-001, a proprietary oral capsule formulation of niclosamide as a safe, widely accessible antiviral treatment for COVID-19. The company partnered with Quotient Sciences to manufacture the drug candidate and received FDA clearance to proceed to human clinical trials, making it one of the first COVID-19 treatment companies to enter Phase II/III trials with a niclosamide-based therapy. Backed by SOSV and a $5M seed round in August 2020, the company was acquired by NeuroBo Pharmaceuticals (Nasdaq: NRBO) in January 2021 for late-stage oral antiviral development. The neurobopharma.com domain now operates as MetaVia, NeuroBo's rebranded entity focused on cardiometabolic diseases.

Summary

ANA Therapeutics is a Biotech company based in Foster City, United States, founded in 2020. It has raised $5.0M in total across 2 rounds, most recently a $5.0M Seed round in Aug 2020. Investors include SOSV, Sam Altman and Jack Abraham.